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Elm1p Is One of Three Upstream Kinases
for the Saccharomyces cerevisiae SNF1 Complex
mon features. Both are heterotrimeric complexes com-
prising related , , and  subunits [1, 2]. Genes encod-
ing the catalytic  subunit (SNF1) [3], the  subunit
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and D. Grahame Hardie1,* (SNF4) [4], and at least one  subunit (SIP1, SIP2, or
GAL83) are essential for function in yeast [5], while coex-1Division of Molecular Physiology
2 Division of Gene Regulation & Expression pression of all three subunits is required to obtain active
kinase in mammalian cells [6]. The SNF1 complex isSchool of Life Sciences and Wellcome
Trust Biocentre required for the switch from glucose to other carbon
sources, as well as for the switch from fermentative toUniversity of Dundee
Dundee DD1 5EH, Scotland oxidative metabolism [7]. AMPK is a sensor of cellular
energy status that has a wide range of functions [2].United Kingdom
3 Department of Molecular Genetics However, an interesting parallel with SNF1 is that, in
muscle, it is involved in the switch from the anaerobicand Biochemistry
University of Pittsburgh School of Medicine metabolism of endogenous fuels (e.g., glycogen) to the
oxidative metabolism of exogenous glucose and fattyPittsburgh, Pennsylvania 15261
acids [2, 8]. Both SNF1 and AMPK are activated by
glucose deprivation [9, 10], while AMPK is activated
by a variety of stresses that deplete ATP [2], includingSummary
exercise in skeletal muscle [11]. In both cases, activation
requires phosphorylation by upstream kinase(s) at aBackground: The yeast SNF1 protein kinase and the
mammalian AMP-activated protein kinase are highly conserved threonine residue in the activation loop of
the  subunit kinase domain (Thr210 in yeast; Thr172 inconserved heterotrimeric complexes that are “meta-
bolic master switches” involved in the switch from fer- mammals) [9, 12–14]. Identifying these upstream ki-
nases, which have not yet emerged either from geneticmentative/anaerobic to oxidative metabolism. They are
activated by cellular stresses that deplete cellular ATP, screens in yeast or from biochemical studies in mam-
mals, has been a key, unsolved problem in both systems.and SNF1 is essential in the response to glucose starva-
tion. In both cases, activation requires phosphorylation Using a library of protein fusions containing 119 pro-
tein kinases predicted from the yeast genome [15], weat a conserved threonine residue within the activation
loop of the kinase domain, but identifying the upstream have identified Elm1p as the sole kinase that activated
the bacterially expressed kinase domain of AMPK inkinase(s) responsible for this has been a challenging,
unsolved problem. vitro. Elm1p also activated the SNF1 complex and phos-
phorylated Thr210 in vitro. Although we provide evi-Results: Using a library of strains that express 119 yeast
protein kinases as GST fusions, we identified Elm1p as dence that Elm1p can act upstream of SNF1 in vivo,
elm1 strains do not have an snf phenotype, whichthe sole kinase that could activate the kinase domain
of AMP-activated protein kinase in vitro. Elm1p also suggested that there must be other kinases upstream
of Snf1p in vivo. Elm1p is part of a small subfamily ofactivated the purified SNF1 complex, and this correlated
with phosphorylation of Thr210 in the activation loop. yeast protein kinases with Pak1p and Tos3p [16]. We
also report that a triple elm1 pak1 tos3mutant doesRemoval of the C-terminal domain increased the Elm1p
kinase activity, indicating that it is auto-inhibitory. Ex- indeed have an snf phenotype, showing that these
three kinases act upstream of SNF1 in vivo in a partiallypression of activated, truncated Elm1p from its own
promoter gave a constitutive pseudohyphal growth phe- redundant manner.
notype that was rescued by deletion of SNF1, showing
that Snf1p was acting downstream of Elm1p. Deletion
Resultsof ELM1 does not give an snf phenotype. However,
Elm1p is closely related to Pak1p and Tos3p, and a
Elm1p Activates the Bacterially Expressedpak1 tos3 elm1 triple mutant had an snf1 pheno-
AMPK Kinase Domaintype, i.e., it would not grow on raffinose and did not
From each of the strains expressing a single glutathione-display hyperphosphorylation of the SNF1 target,
S-transferase (GST)-protein kinase fusion [15], we puri-Mig1p, in response to glucose starvation.
fied the fusion protein and assayed its ability to activateConclusions: Elm1p, Pak1p, and Tos3p are upstream
a GST fusion of the bacterially expressed kinase domainkinases for the SNF1 complex that have partially redun-
of the1 subunit of rat AMPK. We have previously showndant functions.
that this substrate can be activated by mammalian
AMPKK, and that this is abolished by mutation of Thr172Introduction
[17]. We reasoned that it was valid to use mammalian
AMPK as substrate, because the sequences aroundThe yeast SNF1 complex and its mammalian homolog,
AMP-activated protein kinase (AMPK), have many com- Thr210 (Snf1p) and Thr172 (AMPK-) are highly con-
served, and because a mammalian upstream kinase can
activate the yeast SNF1 complex in vitro [9]. Of the 119*Correspondence: d.g.hardie@dundee.ac.uk
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Figure 1. Elm1p Activates the Kinase Do-
main of Mammalian AMPK in Cell-Free
Assays and Is Activated by Proteolytic Re-
moval of the C Terminus
(A) Activation of the 1 kinase domain by fu-
sions between GST and yeast protein ki-
nases; mammalian AMPKK1 is a positive con-
trol. A bar chart showing the activation of
the bacterially expressed AMPK 1 kinase
domain by 119 yeast protein kinase-GST fu-
sions and by AMPKK1. The results are ex-
pressed relative to the activation obtained
with AMPKK1. Only the kinases giving a posi-
tive signal (GST-Elm1p and AMPKK1) are la-
beled.
(B) A Western (anti-GST) blot of four GST-Elm1p
preparations (lanes 1-4), and a Colloidal Blue-
stained gel of large-scale preparation (lane
5). L, crude cell lysates; P, glutathione-Seph-
arose precipitates. The kinase kinase activi-
ties in the P fractions are given below each
lane.
(C) The predicted amino acid sequence of
Elm1p. The large shaded box enclosed in
dashed lines represents the kinase domain,
based on alignments with other kinases.
Tryptic peptides identified in the fingerprint-
ing analysis of the 65 kDa fragment are high-
lighted by using smaller boxes with continu-
ous lines.
purified GST kinases tested, only Elm1p gave a signal that body was fused at the N terminus, the 65 kDa polypep-
was well above background and was similar to the signal tide appeared to be truncated at the C terminus. To
obtained with mammalian AMPKK1 [18] (Figure 1A). confirm this, we made a larger scale preparation (lane
5, Figure 1B), excised the 65 kDa fragment from the gel,
digested it with trypsin, and analyzed the masses of theThe C-Terminal Region of Elm1p
peptide mixture obtained by MALDI-TOF mass spec-Is an Auto-Inhibitory Domain
trometry. We could identify 14 peptides from the kinaseTo confirm these findings, we made several preparations
domain, corresponding to 43% of the total sequenceof GST-Elm1p, but their activity was variable. When ex-
(Figure 1C). The peptides identified covered the regionamined by Western blotting with anti-GST antibodies,
from residues 84 to 404, including almost the entirewe observed a 65 kDa polypeptide as well as the full-
kinase domain. Tryptic peptides derived from GST werelength 100 kDa GST-Elm1p (Figure 1B). Interestingly,
also detected, but we did not detect any peptides fromthe highest activity was found in the preparation that
the CTD. These results suggested that the CTD was ancontained the highest proportion of 65 kDa polypeptide.
auto-inhibitory domain, and, to confirm this, we ex-The Elm1p sequence contains a central kinase domain
pressed DNA encoding full-length Elm1p, or Elm1p with(141–420), followed by a large C-terminal domain
(CTD, 421–640). Since the GST detected by the anti- the CTD removed (residues 1–420; Elm1p-C), from a
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Elm1p Activates the SNF1 Complex
and Phosphorylates Thr210 In Vitro
Elm1p-C also activated the dephosphorylated SNF1
complex purified from yeast in a dose-dependent man-
ner (Figure 2B). To test whether this was due to phos-
phorylation of Thr210, we utilized a phosphospecific
antibody [19] against Thr172 on mammalian AMPK
(apart from a conservative [Arg→Lys] replacement at
the third residue, the sequence of the peptide antigen
is perfectly conserved in Snf1p). Figure 2C (upper panel,
lanes 1 and 2) shows that treatment with protein phos-
phatase-2A removed almost all of the phosphate from
Thr210, while Elm1p-C caused a dose-dependent in-
crease in phosphorylation of Thr210 in the presence of
MgATP (lanes 3–7). These findings correlate with the
activation shown in Figure 2B. The lower panel shows
reprobing of the same blot with a nonphosphospecific
Snf1p antibody to confirm equal loading.
Expression of Activated Elm1p In Vivo Gives
an Snf-Dependent Phenotype
To examine the effect of the truncated, activated Elm1p
in vivo, we compared a strain expressing the normal
full-length ELM1 with a strain in which the DNA encoding
the CTD (residues 421–640) had been deleted from the
endogenous gene. Using anti-Elm1p antibody, the ex-
pression of full-length and truncated Elm1p was identi-
cal (not shown). Cells were grown in medium containing
1 M sorbitol, since it was found that some of the strains
described below were osmotically sensitive. Kinase ki-
nase assays in anti-Elm1p immunoprecipitates con-
firmed that the Elm1p-C strain had an activity that was
6-fold greater than that of the strain expressing full-
length Elm1p. Figure 3 shows the appearance of colo-
nies of these strains and others derived from them. The
strain expressing full-length Elm1p (Figure 3A) and an
snf1 strain (Figure 3B) gave normal, round colonies
Figure 2. Elm1p Contains an Auto-Inhibitory Domain at the C Termi- with a smooth margin. By contrast, cells expressing
nus and Activates the SNF1 Complex by Phosphorylation of Thr210 Elm1p-C gave colonies with a ragged, irregular margin
(A) Expression (left) and kinase kinase activity (right) of Elm1p-C (Figure 3C). Deletion of the SNF1 gene in cells express-
compared with full-length Elm1p. The protein kinases were ex- ing Elm1p-C caused reversion to smooth colonies (Fig-pressed from a GAL1 promoter, purified via hexahistidine tags, and
ure 3D), suggesting that Snf1p acted downstream ofanalyzed by Western blotting (left) with an anti-Elm1p antibody
Elm1p to produce this phenotype. Consistent with this,(yN-19, Santa Cruz) or via kinase kinase assays (right).
(B and C) (B) Activation and (C) phosphorylation at Thr210 of the the ragged colonies were regained by expressing from a
dephosphorylated SNF1 complex by Elm1p-C. (B) Activation of the plasmid wild-type Snf1p (Figure 3E), but not a Thr210Ala
dephosphorylated, purified SNF1 complex by increasing amounts mutant (Figure 3F). The latter would be incapable of
of the hexahistidine-tagged Elm1p-C; results are expressed as a being phosphorylated and activated by the upstreampercentage of the activity of the SNF1 complex prior to dephosphor-
kinase.ylation. (C) Upper panel: phosphorylation of Thr210 assessed by
These strains and others derived from them were alsoprobing blots with a phosphospecific antibody against the Thr172
site on mammalian AMPK [19]. Key to lanes: (1) purified SNF1 com- studied by differential interference contrast microscopy
plex without phosphatase treatment; (2–7) phosphatase-treated (Figure 4). Cells expressing full-length Elm1p (Figure 4A)
SNF1 complex treated with 0, 0.09, 0.18, 0.45, 0.9, and 1.8g Elm1p- and an snf1 strain (Figure 4B) had a normal, rounded
C, as in (B). Lower panel: the same blot was stripped and reprobed appearance with single buds. By contrast, cells express-with anti-Snf1p antibody (yK-16, Santa Cruz) to ensure uniform
ing Elm1p-C were misshapen, had elongated morphol-loading.
ogy, and had a pseudohyphal growth pattern that
caused the mother and daughter cells to fail to separate
(Figure 4C). When we deleted SNF1 in the strain express-plasmid with a GAL1 promoter. The products were puri-
fied via hexahistidine tags and were the expected size ing Elm1p-C, the morphology reverted to normal (Fig-
ure 4D). Western blotting confirmed that the expressionwhen probed with an anti-Elm1p antibody (Figure 2A,
left panel). Although both protein products were active, of Elm1p-C was not affected by the SNF1 deletion
(not shown). The elongated cells/pseudohyphal growththe truncated product was 9-fold more active than the
full-length protein (Figure 2A, right panel). phenotype was restored to the Elm1p-C snf1 strain
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Figure 3. Appearance under the Dissecting
Microscope of Colonies of Different Strains
(A) A strain expressing (from its own pro-
moter) full-length Elm1p with a protein A tag.
(B) A strain deleted for SNF1 in the same
background.
(C) The same strain as in (A), but expressing
C-terminally truncated (1–420) Elm1p (Elm1p-
C).
(D) The same strain as in (C), but with SNF1
also deleted.
(E) The same strain as in (D), but expressing
plasmid pRJ79 encoding a Snf1p-VP16
fusion.
(F) The same strain as in (D), but expressing
plasmid pRJ81 encoding a Snf1p(T210A)-
VP16 fusion.
All pictures were taken at 16 magnification.
by expression of wild-type Snf1p (Figure 4E), but not a prone to rupture, even in 1 M sorbitol, was more severe
than either of the single disruptions.Thr210Ala mutant (Figure 4F). As expected [20], deletion
of endogenous ELM1 yielded elongated cells with a
pseudohyphal growth pattern (Figure 4G). However, un- A pak1 tos3 elm1 Triple Mutant Has
an snf Phenotypelike the Elm1p-C strain, the morphology of this strain
was not normalized by deletion of SNF1 (Figure 4H). While these studies with Elm1p were being carried out
by one of our two groups, the other group [21] reportedThe phenotype of the double disruptant, which involved
large cells that flattened under the coverslip, cells that that the protein kinase Pak1p could also phosphorylate
Thr210 on Snf1p in vitro and provided genetic evidencedid not detach from each other, and cells that were very
Figure 4. Appearance by Differential Interfer-
ence Contrast Microscopy of Cells of Differ-
ent Strains
(A) A strain expressing (from its own pro-
moter) full-length protein A-tagged Elm1p.
(B) An snf1 deletion in the same genetic
background.
(C) The same strain as in (A), but expressing
C-terminally truncated (1–420), rather than
full-length, Elm1p (Elm1p-C).
(D) The same strain as in (C), but with an
additional snf1 deletion.
(E) The same strain as in (D), but also express-
ing plasmid pRJ79 encoding a Snf1p-VP16
fusion.
(F) The same strain as in (D), but also express-
ing plasmid pRJ81 encoding a Snf1p(T210A)-
VP16 fusion.
(G) An elm1 deletion in the same back-
ground.
(H) An ELM1 SNF1 double disruptant (elm1
snf1).
The scale bars are 5 m.
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Growth on raffinose was restored by providing SNF1 on
a plasmid instead. Figure 5A shows that a pak1 tos3
elm1 triple mutant also had an snf phenotype in that
it would grow on glucose but not on raffinose. Provision
of either PAK1, ELM1, or TOS3 function on a plasmid
allowed growth on raffinose, providing strong evidence
that any one of these three kinases can activate the
SNF1 complex in vivo.
Growth on raffinose requires derepression of the in-
vertase gene (SUC2) via multiple phosphorylation of the
repressor protein, Mig1p, by the SNF1 complex [22, 23].
Figure 5B shows that multiple phosphorylation of HA-
tagged Mig1p on transfer of a wild-type strain to low
glucose was evident as reduced mobility on a Western
blot. The hyperphosphorylation of Mig1p in response to
low glucose was completely abolished in an snf110
strain and in a pak1 tos3 elm1 triple mutant.
Discussion
Our approach using the library of yeast strains express-
ing GST-protein kinase fusions [15] detected Elm1p, but
not Pak1p or Tos3p, as an upstream kinase for the SNF1
complex. There are several reasons why this approach
might fail to find all protein kinases acting upstream of
SNF1. For example, the GST domain might interfere
with enzymatic function, or the kinase might require
additional inputs, such as covalent modifications or in-
teraction with regulatory subunits. Indeed, we might
have missed Elm1p if there had not been some fortuitous
degradation of the protein to generate an active frag-
ment (Figure 1B). Our results support the idea that the
CTD of Elm1p (residues 421–640) is an auto-inhibitory
domain that represses the kinase activity. Koehler and
Myers [24] previously reported that Elm1p lacking the
Figure 5. The Pak1p, Elm1p, and Tos3p Kinases Are Required for
CTD was functional in vivo and displayed some kinaseSnf1p Function
activity against artificial substrates, but they did not
(A) Comparison of the growth properties of yeast cells lacking either
address whether the truncation caused a quantitativeSnf1p or the Snf1p-activating kinases. Equivalent numbers of cells
effect on Elm1p function. We are not proposing thatwere spotted onto synthetic complete media lacking leucine and
containing either glucose (Glu) or raffinose (Raf) as the carbon proteolysis is a physiological mode of regulation of
source. The yeast strains used (FY1193 (snf110) and MSY858 Elm1p, but instead that there is some natural stimulus
(pak1 elm1 tos3)) were transformed with either empty vector (perhaps during cytokinesis, see below) that relieves
(V) or plasmids containing the indicated gene. inhibition by the CTD via an allosteric transition or a
(B) Snf1-dependent phosphorylation of Mig1 is blocked in pak1
reversible covalent modification.elm1 tos3 cells. Cells were transformed with a plasmid expressing
The results in Figure 2 show that Elm1p activates theMig1 protein tagged with the HA epitope. Protein extracts prepared
from cells grown in high (H, 2%; lanes 1, 3, and 5) or low (L, 0.05%; SNF1 complex by phosphorylation of Thr210 on Snf1p,
lanes 2, 4, and 6) glucose were analyzed by Western blotting. The while results supporting the idea that this can occur in
yeast strains used in this study were MSY182 (WT; lanes 1 and 2), vivo are presented in Figures 3 and 4. When compared
FY1193 (snf110; lanes 3 and 4), and MSY858 (pak1 elm1 tos3; with cells expressing full-length Elm1p, expression from
lanes 5 and 6). The mobility of the Mig1p protein and phosphorylated
the endogenous promoter of an activated Elm1p lackingMig1p (Mig1-P) is indicated. The lower panel shows a Coomassie
the inhibitory CTD (Elm1p-C) produced colonies withblue-stained gel run in duplicate to show that the six extracts con-
tained equivalent quantities of total protein. a ragged margin, elongated cell morphology, and pseu-
dohyphal growth, the latter presumably being responsi-
ble for the unusual colony shape. This was dependent
on the function of Snf1p, because the cell and colonythat it acted upstream of the SNF1 complex in vivo.
However, pak1 deletion did not cause an snf pheno- shape reverted to normal if the SNF1 gene was deleted
in the strain expressing the activated Elm1p-C. More-type, suggesting that Snf1 may be activated in vivo by
other upstream kinases in addition to Pak1p. Intrigu- over, the ability of Snf1p to mediate the effect of acti-
vated Elm1p required an intact phosphorylation site, i.e.,ingly, the kinase domains of Elm1p and Pak1p are
closely related to each other and to that of Tos3p [16]. Thr210, because the phenotype reverted upon expres-
sion of wild-type Snf1p, but not a Thr210Ala mutant. ThisFigure 5A shows that an snf110 strain would grow on
glucose (Glu), but not on raffinose (Raf) as expected. suggests that the unusual cell growth pattern requires
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phosphorylation of Thr210 by Elm1p-C, and that the could be restored by provision of any one of the three
latter is acting as an upstream kinase for Snf1p. kinases on a plasmid. In addition, the hyperphosphoryla-
ELM1 was originally defined via mutations that caused tion of Mig1p that occurred in response to glucose depri-
an elongated cell morphology (ELM), constitutive, pseu- vation of a wild-type strain was abolished in an snf110
dohyphal growth, and invasion of agar [20]. Pseudohy- strain and in the pak1 tos3 elm1 triple mutant. Thus,
phal, invasive growth normally only occurs upon nutrient while any one of these three kinases can activate the
starvation, and it is viewed as a mechanism to allow SNF1 complex in vivo, the presence of at least one of
yeast to forage for nutrients. Intriguingly, starvation for them is essential for SNF1 function.
glucose and other fermentable sugars causes invasive One of our original aims was to use the yeast system
filamentous growth of haploid yeast, and this response to identify upstream kinases that might enable us to
requires SNF1 [25]. Surprisingly, none of the strains identify homologs in mammals. Unfortunately, searches
studied by us in Dundee (even elm1) invaded agar of predicted mammalian proteins reveal no clear homo-
significantly, but this may be a function of genetic back- log of Elm1p, Pak1p, or Tos3p. The best matches are
ground [26] Additional insights into the role(s) of Elm1p to the two isoforms of calmodulin-dependent protein
came from findings of genetic interactions with the cell kinase kinase (CaMKK), which is the upstream kinase
cycle controller, Cdc28p [27]. Expression of ELM1 that activates calmodulin-dependent protein kinases I
mRNA [28] and protein [29] is maximal at the time of and IV via phosphorylation of a threonine residue in the
cytokinesis. In elm1 mutants, the septin Cdc11p, a activation loop equivalent to Thr172 in AMPK- and
cytoskeletal protein that (with other septins) forms the Thr210 in Snf1p [30]. Although the sequence similarity
10 nm filament in the bud neck, is mislocalized and is was confined to the kinase domain, this was intriguing
found throughout the bud, and cytokinesis is delayed because one of our groups had already shown that
[27]. Expression of an Elm1p-GFP fusion from the ELM1 CaMKK can activate AMPK in cell-free assays [31]. We
promoter suggested that Elm1p also localizes to the bud do not believe that the upstream kinases previously puri-
neck [27, 29]. Interestingly, overexpression or deletion of fied from rat liver [13, 18] are CaMKKs because: (i) they
ELM1 result in elongated cell morphology, and it was were not stimulated by Ca2 and calmodulin; (ii) relative
suggested that overexpression might cause mislocaliza- to CaMKK, they were more efficient at activating AMPK
tion, because an Elm1p-GFP fusion failed to localize to and less efficient at activating CaMKI; and (iii) they are
the bud neck when overexpressed [29]. This may be not immunoprecipitated by anti-CaMKK antibodies
related to our observations that the phenotype of a strain (Jennifer Reid, personal communication). However, it
expressing an activated Elm1p (Elm1p-C) was superfi- seems likely that the true AMPKKs may correspond to
cially similar to that of an elm1 strain. However, the one or more of the predicted mammalian protein kinases
two strains differed in the effect of the additional deletion with kinase domains related to those of the CaMKKs,
of SNF1 (Figure 4), and this difference rules out the many of which still have unknown functions.
possibility that Elm1p-C was simply acting as a domi-
nant-negative mutant.
These results suggested that the activated Elm1p Conclusions
could phosphorylate and activate the SNF1 complex in We have identified Elm1p as an upstream kinase that
vivo, but because elm1 strains do not have an snf can phosphorylate and activate the SNF1 complex in
phenotype, it remained formally possible that this was vitro and in vivo. Elm1p contains a regulatory C-terminal
a function that was not performed by normal, full-length domain whose influence can be removed by proteolysis
Elm1p. However, an alternative explanation for the lack or truncation, but which may be regulated physiologi-
of an snf phenotype in elm1 strains was that there
cally by some other unknown mechanism. Our results
were multiple kinases acting upstream of the SNF1 com-
and those published previously [21] identify Elm1p,
plex that are partially redundant. While the studies of
Pak1p, and Tos3p as a subfamily of yeast kinases that
Elm1p were being performed by one of our two groups,
can phosphorylate Thr210 on Snf1p, and at least onethe other group reported that Pak1p could phosphory-
of these is required for activation of the SNF1 complexlate Snf1p at Thr210 in vitro, and they also provided
in vivo. Although these kinases are partially redundantgenetic evidence that Pak1p activates the SNF1 com-
with respect to this function, deletion of the individualplex in vivo [21]. Intriguingly, Pak1p, Tos3p, and Elm1p
kinases causes different phenotypes, so they may phos-form a small protein kinase subfamily in yeast; the kinase
phorylate the SNF1 complex under different conditions,domains of the first two are particularly closely related
or at different times or subcellular locations, in vivo.[16]. We therefore constructed a pak1 tos3 elm1
Furthermore, phenotypic variation may be explained iftriple mutant. Like an snf1 strain, the triple mutant
Pak1, Tos3, and Elm1 kinases were to activate additionalwould grow on glucose but not on raffinose. Metabolism
and distinct sets of downstream kinases [32]. Furtherof raffinose requires the derepression of the SUC2 gene,
work is required to delineate their differing physiologicalencoding invertase. Derepression of SUC2 is achieved,
roles, but their overlapping function in activation of theat least in part, via phosphorylation of Mig1p by the
SNF1 complex explains why these kinases have notSNF1 complex at four serine residues within the central
emerged from previous genetic screens that identifiedR1 domain [22]. This in turn promotes binding of Mig1p
genes that interact with SNF1. Although Elm1p, Pak1p,to the nuclear export protein, Msn5p, and the conse-
and Tos3p do not have direct homologs in mammals, ourquent translocation of the repressor protein to the cyto-
results should assist in the identification of the elusiveplasm [23]. As shown in Figure 5A, the growth defect
of the pak1 tos3 elm1 triple mutant on raffinose upstream kinases in the mammalian AMPK system.
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